Regen BioPharma Inc (RGBP) stock
RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026Market cap $92.33KP/E –Yield –
Regen BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Regen BioPharma's enterprise value was $169.26K on Oct 19, 2026, against $407.35K a year earlier. Over the last 5 years it ranged from $891 to $54.16B, with a median of $1.52M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $169.26K | -23.7% |
| 2025 | Dec 31, 2025 | $221.82K | -39.9% |
| 2024 | Dec 31, 2024 | $368.94K | -78.2% |
| 2023 | Dec 29, 2023 | $1.69M | -82.6% |
| 2022 | Dec 30, 2022 | $9.76M | -100.0% |
| 2021 | Dec 31, 2021 | $47.80B | +3871.0% |
| 2020 | Dec 31, 2020 | $1.20B | +1237.6% |
| 2019 | Dec 31, 2019 | $89.99M | -76.2% |
| 2018 | Dec 31, 2018 | $378.65M | -92.9% |
| 2017 | Dec 29, 2017 | $5.34B | -37.9% |
| 2016 | Dec 30, 2016 | $8.60B | -35.6% |
| 2015 | Dec 31, 2015 | $13.34B | +146.2% |
| 2014 | Dec 31, 2014 | $5.42B | – |
See a number that looks wrong?